Carlos D. Flombaum

3.0k total citations
40 papers, 2.2k citations indexed

About

Carlos D. Flombaum is a scholar working on Pulmonary and Respiratory Medicine, Nephrology and Molecular Biology. According to data from OpenAlex, Carlos D. Flombaum has authored 40 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 12 papers in Nephrology and 10 papers in Molecular Biology. Recurrent topics in Carlos D. Flombaum's work include Chemotherapy-induced organ toxicity mitigation (6 papers), Renal cell carcinoma treatment (5 papers) and Renal Diseases and Glomerulopathies (5 papers). Carlos D. Flombaum is often cited by papers focused on Chemotherapy-induced organ toxicity mitigation (6 papers), Renal cell carcinoma treatment (5 papers) and Renal Diseases and Glomerulopathies (5 papers). Carlos D. Flombaum collaborates with scholars based in United States, France and Poland. Carlos D. Flombaum's co-authors include Ilya Glezerman, Ephraim S. Casper, David P. Kelsen, Robert T. Heelan, Thomas D. Brown, Peter G. Tarassoff, Bonnie J. Trochanowski, Mark R. Green, Ki Y. Chung and Leonard B. Saltz and has published in prestigious journals such as JAMA, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Carlos D. Flombaum

40 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carlos D. Flombaum United States 24 749 642 590 373 349 40 2.2k
Hassan Izzedine France 27 530 0.7× 738 1.1× 410 0.7× 559 1.5× 271 0.8× 94 2.1k
Xiaolei Zhu China 14 830 1.1× 678 1.1× 604 1.0× 160 0.4× 219 0.6× 35 2.1k
Isabelle Brochériou France 28 297 0.4× 674 1.0× 434 0.7× 638 1.7× 195 0.6× 129 2.4k
Sri Harsha Tella United States 23 967 1.3× 414 0.6× 818 1.4× 234 0.6× 263 0.8× 95 2.5k
Abdurrahman Oğuzhan Türkiye 23 762 1.0× 432 0.7× 452 0.8× 324 0.9× 182 0.5× 89 2.8k
Alan P.B. Dackiw United States 32 632 0.8× 423 0.7× 492 0.8× 582 1.6× 234 0.7× 79 3.0k
F. W. Schildberg Germany 21 712 1.0× 449 0.7× 712 1.2× 59 0.2× 251 0.7× 45 2.5k
Uğur Çoşkun Türkiye 26 862 1.2× 557 0.9× 535 0.9× 57 0.2× 199 0.6× 174 2.3k
P. Scigalla Germany 24 892 1.2× 906 1.4× 1.2k 2.0× 310 0.8× 152 0.4× 82 3.7k
Viviane Gnemmi France 23 250 0.3× 268 0.4× 721 1.2× 490 1.3× 213 0.6× 83 2.2k

Countries citing papers authored by Carlos D. Flombaum

Since Specialization
Citations

This map shows the geographic impact of Carlos D. Flombaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos D. Flombaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos D. Flombaum more than expected).

Fields of papers citing papers by Carlos D. Flombaum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos D. Flombaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos D. Flombaum. The network helps show where Carlos D. Flombaum may publish in the future.

Co-authorship network of co-authors of Carlos D. Flombaum

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos D. Flombaum. A scholar is included among the top collaborators of Carlos D. Flombaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos D. Flombaum. Carlos D. Flombaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Flombaum, Carlos D., et al.. (2018). Management of Patients with Acute Methotrexate Nephrotoxicity with High‐Dose Leucovorin. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 38(7). 714–724. 20 indexed citations
2.
Flombaum, Carlos D., et al.. (2012). Long term renal toxicity of ifosfamide in adult patients – 5year data. European Journal of Cancer. 48(9). 1326–1331. 26 indexed citations
3.
Landau, Heather, Hani Hassoun, Michael Rosenzweig, et al.. (2012). Bortezomib and dexamethasone consolidation following risk-adapted melphalan and stem cell transplantation for patients with newly diagnosed light-chain amyloidosis. Leukemia. 27(4). 823–828. 79 indexed citations
4.
Latcha, Sheron, Robert G. Maki, Gary K. Schwartz, & Carlos D. Flombaum. (2009). Ifosfamide May Be Safely Used in Patients with End Stage Renal Disease on Hemodialysis. Sarcoma. 2009. 1–5. 6 indexed citations
5.
Glezerman, Ilya, Mark G. Kris, V.A. Miller, Surya V. Seshan, & Carlos D. Flombaum. (2009). Gemcitabine nephrotoxicity and hemolytic uremic syndrome: report of 29 cases from a single institution. Clinical Nephrology. 71(2). 130–139. 81 indexed citations
6.
Hassoun, Hani, Carlos D. Flombaum, Vivette D. D’Agati, et al.. (2008). High-dose melphalan and auto-SCT in patients with monoclonal Ig deposition disease. Bone Marrow Transplantation. 42(6). 405–412. 38 indexed citations
7.
Feldman, Darren R., Michelle S. Ginsberg, Michael Baum, et al.. (2008). Phase I trial of bevacizumab plus sunitinib in patients with metastatic renal cell carcinoma. Journal of Clinical Oncology. 26(15_suppl). 5100–5100. 33 indexed citations
8.
Schrag, Deborah, Ki Y. Chung, Carlos D. Flombaum, & Leonard B. Saltz. (2005). Cetuximab Therapy and Symptomatic Hypomagnesemia. JNCI Journal of the National Cancer Institute. 97(16). 1221–1224. 175 indexed citations
9.
Morris, Michael J., Òren Smaletz, David B. Solit, et al.. (2004). High‐dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinoma. Cancer. 100(9). 1868–1875. 30 indexed citations
10.
Motzer, Robert J., Madhu Mazumdar, Joel Sheinfeld, et al.. (2000). Sequential Dose-Intensive Paclitaxel, Ifosfamide, Carboplatin, and Etoposide Salvage Therapy for Germ Cell Tumor Patients. Journal of Clinical Oncology. 18(6). 1173–1180. 136 indexed citations
11.
Flombaum, Carlos D., et al.. (1999). Thrombotic microangiopathy as a complication of long-term therapy with gemcitabine. American Journal of Kidney Diseases. 33(3). 555–562. 61 indexed citations
12.
Flombaum, Carlos D. & Paul A. Meyers. (1999). High-Dose Leucovorin as Sole Therapy for Methotrexate Toxicity. Journal of Clinical Oncology. 17(5). 1589–1589. 72 indexed citations
13.
Aledo, Alexander, Glenn Heller, Sharon L. Gardner, et al.. (1998). Septicemia and Septic Shock in Pediatric Patients. Journal of Pediatric Hematology/Oncology. 20(3). 215–221. 26 indexed citations
14.
Flombaum, Carlos D., Marian Isaacs, Lillian Reich, Ellin Berman, & Raymond P. Warrell. (1996). Acute renal failure associated with the retinoic acid syndrome in acute promyelocytic leukemia. American Journal of Kidney Diseases. 27(1). 134–137. 9 indexed citations
15.
Flombaum, Carlos D., et al.. (1994). Na speciation affects the Na-P-o5m relationship and may explain in part the hyponatremia of hypoalbuminemic states. Journal of the American Society of Nephrology. 5(3). 367. 2 indexed citations
16.
Casper, Ephraim S., Mark R. Green, David P. Kelsen, et al.. (1994). Phase II trial of gemcitabine (2,2′-difiuorodeoxycytidine) in patients with adenocarcinoma of the pancreas. Investigational New Drugs. 12(1). 29–34. 372 indexed citations
17.
Motzer, Robert J., Donna Niedzwiecki, Celia J. Menendez‐Botet, et al.. (1990). Carboplatin-based chemotherapy with pharmacokinetic analysis for patients with hemodialysis-dependent renal insufficiency. Cancer Chemotherapy and Pharmacology. 27(3). 234–238. 24 indexed citations
18.
Flombaum, Carlos D. & Yitshal Berner. (1989). TPN-induced catch-up of growth in a 22-y-old male with radiation enteritis. American Journal of Clinical Nutrition. 50(6). 1341–1347. 4 indexed citations
19.
Flombaum, Carlos D.. (1984). Hypomagnesemia Associated With Cisplatin Combination Chemotherapy. Archives of Internal Medicine. 144(12). 2336–2336. 7 indexed citations
20.
Flombaum, Carlos D., Shyan–Yih Chou, Jerome G. Porush, et al.. (1978). Serial evaluation of the renin-angiotensin-aldosterone system in caval dogs.. Circulation Research. 42(6). 778–786. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hassan Izzedine Breakdown of academic impact, for papers by Xiaolei Zhu Breakdown of academic impact, for papers by Isabelle Brochériou Breakdown of academic impact, for papers by Sri Harsha Tella Breakdown of academic impact, for papers by Abdurrahman Oğuzhan Breakdown of academic impact, for papers by Alan P.B. Dackiw Breakdown of academic impact, for papers by F. W. Schildberg Breakdown of academic impact, for papers by Uğur Çoşkun Breakdown of academic impact, for papers by P. Scigalla Breakdown of academic impact, for papers by Viviane Gnemmi
Rankless by CCL
2026